First Salmonella Vaccine For Poultry To Be On The Market Soon

A biologist at Washington University in St. Louis has developed a live vaccine that should greatly decrease the incidences of food poisoning and deaths in humans infected by salmonella bacteria.

Roy Curtiss III, Ph.D., George William and Irene Koechig Freiberg Professor of Biology in Arts and Sciences, has genetically engineered the most common strain of salmonella infecting chickens and developed it as an oral vaccine to be given to poultry. Curtiss deleted two key genes in the strain Salmonella typhimurium UK-1; the deletion weakens the bacteria, allowing it in vaccine form to induce an immune response in a chicken without making the bird sick.

When given a dose of the vaccine, newborn chicks, breeders and laying hens develop a lifelong immunity to salmonella. The immunity is transferred to offspring and eggs that people consume.

The vaccine is in its final stage of testing by scientists at Megan Health Inc. in St. Louis, a company licensed by Washington University to develop and market vaccines based on technology developed by Curtiss.

The U.S. Department of Agriculture (USDA) is expected to license the vaccine by the end of 1997. Megan's vaccine will be the first salmonella vaccine for poultry marketed in the United States.

Curtiss reported the vaccine test results July 29, 1997, at the International Veterinary Vaccines and Diagnostics Conference, held in Madison, Wis.

"Based on years of research and testing, we are confident that our vaccine works very well," says Curtiss, who first developed the strain for his vaccine in 1990, and has spent 17 years researching salmonella bacteria.

When virulent bacteria are introduced into an organism, a fight ensues between the bacteria and the host's immune system.

"By deleting the genes, we make sure that the salmonella has its hands tied behind its back," Curtiss explains. "With those two genes, the salmonella could defend itself against the chicken's na

Contact: Tony Fitzpatrick
Washington University in St. Louis

Page: 1 2 3 4

Related biology news :

1. First glimpse of DNA binding to viral enzyme
2. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
3. 2nd media alert First Scientific Conference on Childhood Leukaemia
4. First International Scientific Conference on Childhood Leukaemia
5. First ever standards linking climate change, biodiversity and poverty seek global peer review
6. First genetic comparison of purebred domestic dogs produces surprises
7. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
8. First target for childhood malaria vaccine
9. First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely
10. First flavors form a lasting impression
11. STN International launches Derwent World Patents Index First View

Post Your Comments:

(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: